Business
Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering
January 23, 2026 BOSTON, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (the “Company”) announced today that it priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol “HLXC” beginning today. The Company expects the offering to be consummated on January 26, 2026. The Company is a special purpose acquisition company formed for the purpose of effectin
About this update from Helix Acquisition Corp. Iii
[{"type":"text","content":"January 23, 2026","length":16,"tagName":"p"},{"type":"text","content":"BOSTON, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Helix Acquisition Corp. III (the “Company”) announced today that it priced its upsized initial public offering of 15,000,000 Class A ordinary shares at $10.00 per share. The shares will be listed on The Nasdaq Global Market and trade under the ticker symbol “HLXC” beginning today. The Company expects the offering to be consummated on January 26, 2026.","length":395,"tagName":"p"},{"type":"text","content":"The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on opportunities in healthcare or healthcare-related industries. The Company, sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, is led by Bihua Chen as Chief Executive Officer and Chairperson, and Caleb Tripp as Chief Financial Officer and Chief Operating Officer.","length":638,"tagName":"p"},{"type":"text","content":"Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 2,250,000 Class A ordinary shares at the initial public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.","length":346,"tagName":"p"},{"type":"text","content":"The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: Leerink Partners LLC, Attn: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, or by telephone at (800) 808-7525 ext. 6105, or by email at [email protected]; and Oppenheimer & Co. Inc. Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, or by telephone at (212) 667-8055, or by email at [email protected].","length":501,"tagName":"p"},{"type":"text","content":"A registration statement relating to these securities became effective on January 22, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor sh...